Verastem, Inc. (VSTM)

PHARMACEUTICAL PREPARATIONS

Verastem, Inc. (VSTM) is listed on Nasdaq, where it has traded since January 27, 2012.

Listed On
Nasdaq
Listed Since
January 27, 2012
Employees
102
Market Cap
$701M

About Verastem, Inc.

Verastem Inc is late-stage development biopharmaceutical company, committed to advancing new medicines for patients battling cancer. Its pipeline is focused on novel anticancer agents that inhibit critical signaling pathways in cancer that promote cancer cell survival and tumor growth, particularly RAF/MEK inhibition and FAK inhibition.

Institutional ownership

In 13F filings for the quarter ended June 30, 2026, 151 institutions reported holding VSTM, with 94.5 million shares worth $361.3 million in aggregate. The largest reported holder was BlackRock, with 9.2 million shares worth $35.1 million. Of the 5 largest holders listed below, 4 added shares and 1 held its position unchanged during the quarter.

InstitutionSharesValueQuarter change
BlackRock9,192,447$35MAdded 48.39%
Vanguard7,777,714$30MAdded 68.46%
Armistice Capital7,024,000$27MAdded 52.96%
Rtw Investments6,635,793$25MAdded 0.9%
Deep Track Capital5,740,850$22MUnchanged

Form 13F is a quarterly report that institutional investment managers with at least $100 million in qualifying securities file with the SEC. It lists long positions as of the last day of the quarter and is due within 45 days of quarter end, so these holdings describe that date rather than today.

Frequently asked questions

What is VSTM?

Verastem, Inc. (VSTM) is listed on Nasdaq, where it has traded since January 27, 2012.

Who are the largest institutional holders of VSTM?

In 13F filings for the quarter ended June 30, 2026, the largest reported holders of VSTM were BlackRock, Vanguard and Armistice Capital.

How many institutions own VSTM?

151 institutions reported a position in VSTM for the quarter ended June 30, 2026, worth $361.3 million in total.

Did institutions buy or sell VSTM last quarter?

Of the 5 largest reported holders, 4 added shares and 1 held its position unchanged during the quarter. Every reported holder and its change is on the SentiSense ownership page for VSTM.

Every reported institutional holder, plus insider and congressional trades in VSTM, on SentiSense.